Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry refers to a non-coding RNA pseudogene with no evidence for protein expression or therapeutic target status. It is annotated as a pseudogene related to the ELL2 subunit and has alternative names implying possible regulation by NMDA receptor activity. However, there is no substantial information on biological function, disease association, relevance to signaling pathways, or druggability. This \"target\" appears to be either a database artifact, a computational prediction without experimental validation, or a misannotation. No peer-reviewed literature supports this as a molecular target, and it should not be considered a receptor, enzyme, or other druggable gene family member.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interactor of little elongation complex ELL subunit 2 pseudogene 2 (ICE2P2).